Results 221 to 230 of about 27,781 (266)
Some of the next articles are maybe not open access.
In vivo mutagenic interaction of nitrite and ethylenethiourea
Experientia, 1975N-Nitroso-Athylenthioharnstoff induziert Mutationen inSalmonella typhimurium. Diese Verbindung wird im Magen von Mausen aus Natriumnitrit und Athylenthioharnstoff gebildet; ihre Mutagenitat wird mit Hilfe des Mikrokerntests gezeigt.
openaire +2 more sources
Mutagenic potential of temozolomide in bone marrow cells in vivo
Blood, 2006Therapy-related myeloid leukemias (t-MLs) occur in as many as 5% to 10% of patients who are otherwise cured of a primary neoplasm with aggressive multimodal regimens. Many patients with t-MLs or therapy-related myelodysplastic syndrome (t-MDS) have previously received chemotherapeutic agents ...
Hartmut, Geiger +5 more
openaire +2 more sources
Possibilities of routine in vivo mutagenicity testing in mammals
Archiv f�r Toxikologie, 1971In general, mutations have a negative effect on man. Considering the great number of substances inducing mutagenic effects in microorganisms and in cell cultures, the question arises whether these substances are a genetic risk for man, too. Final statements concerning this matter should be based on in vivo investigations which fully take into account ...
openaire +2 more sources
Lack of Mutagenic Effects of Halothane in Mammals In Vivo
Anesthesiology, 1981Rodents were exposed in vivo to various clinical doses of halothane to observe structural chromosome aberrations, micronuclei, sister chromatid exchanges (SCEs), dominant lethal mutations, and interferences with phases of the cell cycle. The frequency of chromosome aberrations in bone marrow cells was not increased after exposing Chinese hamsters to 1 ...
A, Basler, G, Röhrborn
openaire +2 more sources
Evaluation of in vivo mutagenicity of hydroquinone in Muta™ mice
Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2014Hydroquinone (HQ) is used in skin bleaching agents, hair dyes, and finger nail treatments. Many skin-lightening cosmetics that contain HQ are currently marketed in Japan. Concerns have been expressed regarding health risks to the general population because the carcinogenicity of HQ was previously suggested in animal studies.
Mariko, Matsumoto +6 more
openaire +2 more sources
In vitro and in vivo assays of isopropanol for mutagenicity
Environmental and Molecular Mutagenesis, 1993AbstractTo assess the mutagenic potential of isopropanol, an in vitro Chinese hamster ovary (CHO) cell/HGPRT gene mutation assay and a bone marrow micronucleus study in mice were conducted. In the CHO/HGPRT assay, concentration levels ranged from 0.5 to 5.0 mg/ml.
R W, Kapp +7 more
openaire +2 more sources
EPA use of in vivo germ cell mutagenicity data
Environmental and Molecular Mutagenesis, 1991AbstractThe Toxic Substances Control Act (TSCA) provides the U.S. Environmental Protection Agency, Office of Toxic Substances (EPA, OTS) with the authority to regulate chemical use by requiring testing and use restrictions as appropriate to protect human health.
openaire +2 more sources
Chemical mutagen testing on in vivo somatic mammalian cells
Agents and Actions, 1973Possibilities and limitations in the use of in vivo cytogenetic tests on somatic cells are discussed. Special attention is focused on the problems raised by the relative insensivity of the available procedures. It is emphasized that in planning screening tests the accumulated experience from studies with known chromosome breaking chemicals must be ...
openaire +2 more sources
A mutagenic in vivo metabolite of sodium azide
Mutation Research/Environmental Mutagenesis and Related Subjects, 1978Experimental evidence is presented for the presence of a mutagenic metabolite formed in vivo in barley embryos exposed to sodium azide. The mutagenic substance found in extracts after removal of free azide by acidification was partially purified by liquid column chromatography and eluted.
W.M. Owais +5 more
openaire +1 more source
In Vivo Mutagenicity Testing of Arylboronic Acids and Esters
Environmental and Molecular Mutagenesis, 2019Arylboronic acids and esters (referred to collectively as arylboronic compounds) are commonly used intermediates in the synthesis of pharmaceuticals but pose a challenge for chemical syntheses because they are often positive for bacterial mutagenicity in vitro.
Melisa J, Masuda-Herrera +16 more
openaire +2 more sources

